Plus Therapeutics reported $2.37M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
Baxter International USD 2.15B 133M Jun/2026
Cerus USD 19.96M 4.29M Dec/2025
Dr.Reddys Laboratories INR 11.2B 4.16B Jun/2026
Haemonetics USD 223.38M 22.06M Jun/2026
Northwest Biotherapeutics USD 4.56M 244K Sep/2025
Plus Therapeutics USD 2.37M 656K Jun/2026
Sanofi EUR 6.35B 806M Jun/2026
Starpharma Holdings AUD 15.41M 4.87M Jun/2025
Sun Pharmaceuticals INR 97.71B 15.61B Mar/2026
Teva Pharmaceutical Industries USD 3.74B 185M Mar/2026